Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly Geyer

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
JAAPA : Official Journal of the American Academy of Physician Assistants|October 25, 2017
Amiodarone-induced pulmonary toxicityRebecca Colby, Holly Geyer
Current Hematologic Malignancy Reports|September 25, 2017
Approach to MPN Symptom AssessmentHolly Geyer, Ruben A Mesa
Best Practice & Research. Clinical Haematology|September 6, 2014
Assessing disease burden in patients with classic MPNsHolly Geyer, Ruben A Mesa
Expert Opinion on Pharmacotherapy|March 14, 2013
Polycythemia vera: current pharmacotherapy and future directionsBenjamin Hensley, Holly Geyer, Ruben Mesa
Rare Tumors|April 26, 2012
Asian-variant intravascular lymphoma in the African raceHolly Geyer, Nina Karlin, Brian Palen, et al.
Current Hematologic Malignancy Reports|October 9, 2013
The new landscape of therapy for myelofibrosisKrisstina Gowin, Robyn Emanuel, Holly Geyer, et al.
JAAPA : Official Journal of the American Academy of Physician Assistants|February 4, 2016
Perceived efficacy and utility of postgraduate physician assistant training programsKristen K Will, Jennifer Williams, Ginny Hilton, et al.
Pediatrics|January 13, 2026
A State Blueprint to Equip Schools With a Uniform Overdose Response StrategyHolly Geyer, Krystal Renszel, Gary Kirkilas, et al.
Leukemia & Lymphoma|July 24, 2018
Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?Blake T Langlais, Holly Geyer, Robyn Scherber, et al.
Mayo Clinic Proceedings|August 2, 2025
Entering the Fourth Decade of the Opioid Crisis: An Institution's Efforts to Redefine Opioid StewardshipBenjamin Lai, Julie Cunningham, Nancy O'Keefe, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
JAAPA : Official Journal of the American Academy of Physician Assistants|October 25, 2017
Amiodarone-induced pulmonary toxicityRebecca Colby, Holly Geyer
Current Hematologic Malignancy Reports|September 25, 2017
Approach to MPN Symptom AssessmentHolly Geyer, Ruben A Mesa
Best Practice & Research. Clinical Haematology|September 6, 2014
Assessing disease burden in patients with classic MPNsHolly Geyer, Ruben A Mesa
Expert Opinion on Pharmacotherapy|March 14, 2013
Polycythemia vera: current pharmacotherapy and future directionsBenjamin Hensley, Holly Geyer, Ruben Mesa
Rare Tumors|April 26, 2012
Asian-variant intravascular lymphoma in the African raceHolly Geyer, Nina Karlin, Brian Palen, et al.
Current Hematologic Malignancy Reports|October 9, 2013
The new landscape of therapy for myelofibrosisKrisstina Gowin, Robyn Emanuel, Holly Geyer, et al.
JAAPA : Official Journal of the American Academy of Physician Assistants|February 4, 2016
Perceived efficacy and utility of postgraduate physician assistant training programsKristen K Will, Jennifer Williams, Ginny Hilton, et al.
Pediatrics|January 13, 2026
A State Blueprint to Equip Schools With a Uniform Overdose Response StrategyHolly Geyer, Krystal Renszel, Gary Kirkilas, et al.
Leukemia & Lymphoma|July 24, 2018
Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?Blake T Langlais, Holly Geyer, Robyn Scherber, et al.
Mayo Clinic Proceedings|August 2, 2025
Entering the Fourth Decade of the Opioid Crisis: An Institution's Efforts to Redefine Opioid StewardshipBenjamin Lai, Julie Cunningham, Nancy O'Keefe, et al.
Pageof 3